Article Details

Anti-HER2 Treatments Can Cause Pulmonary Toxicities in HER2+ Breast Cancer

Retrieved on: 2021-05-12 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Anti-HER2 Treatments Can Cause Pulmonary Toxicities in HER2+ Breast Cancer. View article details on hiswai:

Excerpt

The main question regarding anti-HER2 monoclonal antibodies is why they cause pulmonary adverse events such as interstitial lung disease.

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up